Franceschini C, Pizza F, Cavalli F, Plazzi G
Neurotherapeutics. 2021; 18(1):6-19.
PMID: 33886090
PMC: 8061157.
DOI: 10.1007/s13311-021-01051-4.
Barateau L, Lopez R, Dauvilliers Y
Curr Treat Options Neurol. 2016; 18(10):43.
PMID: 27549768
DOI: 10.1007/s11940-016-0429-y.
Barateau L, Lopez R, Dauvilliers Y
CNS Drugs. 2016; 30(5):369-79.
PMID: 27155860
DOI: 10.1007/s40263-016-0337-4.
Black S, Yamanaka A, Kilduff T
Prog Neurobiol. 2016; 152:89-113.
PMID: 26721620
PMC: 5114175.
DOI: 10.1016/j.pneurobio.2015.12.002.
Swick T
Nat Sci Sleep. 2015; 7:159-69.
PMID: 26715865
PMC: 4686331.
DOI: 10.2147/NSS.S92140.
Genetic association, seasonal infections and autoimmune basis of narcolepsy.
Singh A, Mahlios J, Mignot E
J Autoimmun. 2013; 43:26-31.
PMID: 23497937
PMC: 4118764.
DOI: 10.1016/j.jaut.2013.02.003.
Narcolepsy: a review.
Akintomide G, Rickards H
Neuropsychiatr Dis Treat. 2011; 7:507-18.
PMID: 21931493
PMC: 3173034.
DOI: 10.2147/NDT.S23624.
Recent advances in the treatment of narcolepsy.
Hirai N, Nishino S
Curr Treat Options Neurol. 2011; 13(5):437-57.
PMID: 21748548
DOI: 10.1007/s11940-011-0137-6.
Narcolepsy: current treatment options and future approaches.
Billiard M
Neuropsychiatr Dis Treat. 2008; 4(3):557-66.
PMID: 18830438
PMC: 2526380.
Antidepressant drugs for narcolepsy.
Vignatelli L, DAlessandro R, Candelise L
Cochrane Database Syst Rev. 2008; (1):CD003724.
PMID: 18254030
PMC: 9030766.
DOI: 10.1002/14651858.CD003724.pub3.
Cataplexy associated with narcolepsy: epidemiology, pathophysiology and management.
Thorpy M
CNS Drugs. 2006; 20(1):43-50.
PMID: 16396523
DOI: 10.2165/00023210-200620010-00004.
Narcolepsy in the older adult: epidemiology, diagnosis and management.
Chakravorty S, Rye D
Drugs Aging. 2003; 20(5):361-76.
PMID: 12696996
DOI: 10.2165/00002512-200320050-00005.
Narcolepsy.
Bassetti
Curr Treat Options Neurol. 2000; 1(4):291-298.
PMID: 11096716
DOI: 10.1007/s11940-999-0019-3.
A patient with coexisting narcolepsy and morbid jealousy showing favourable response to fluoxetine.
Wing Y, Lee S, Chiu H, Ho C, Chen C
Postgrad Med J. 1994; 70(819):34-6.
PMID: 8140016
PMC: 2397587.
DOI: 10.1136/pgmj.70.819.34.
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers.
Mignot E, Renaud A, Nishino S, Arrigoni J, Guilleminault C, Dement W
Psychopharmacology (Berl). 1993; 113(1):76-82.
PMID: 7862832
DOI: 10.1007/BF02244337.
